AR029189A1 - Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento - Google Patents
Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamentoInfo
- Publication number
- AR029189A1 AR029189A1 ARP000105742A ARP000105742A AR029189A1 AR 029189 A1 AR029189 A1 AR 029189A1 AR P000105742 A ARP000105742 A AR P000105742A AR P000105742 A ARP000105742 A AR P000105742A AR 029189 A1 AR029189 A1 AR 029189A1
- Authority
- AR
- Argentina
- Prior art keywords
- separately
- inhibitor
- phosphodiesterase
- preparation
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16315899P | 1999-11-02 | 1999-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR029189A1 true AR029189A1 (es) | 2003-06-18 |
Family
ID=22588737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105742A AR029189A1 (es) | 1999-11-02 | 2000-10-31 | Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1225866A4 (hu) |
JP (1) | JP2003513028A (hu) |
KR (1) | KR20020057988A (hu) |
CN (1) | CN1387404A (hu) |
AP (1) | AP2002002496A0 (hu) |
AR (1) | AR029189A1 (hu) |
AU (1) | AU1357501A (hu) |
BG (1) | BG106748A (hu) |
BR (1) | BR0015270A (hu) |
CA (1) | CA2388333A1 (hu) |
CO (1) | CO5261512A1 (hu) |
CZ (1) | CZ20021512A3 (hu) |
DZ (1) | DZ3225A1 (hu) |
EA (1) | EA200200518A1 (hu) |
EC (1) | ECSP003747A (hu) |
HK (1) | HK1049107A1 (hu) |
HU (1) | HUP0203152A3 (hu) |
IL (1) | IL149367A0 (hu) |
MA (1) | MA26841A1 (hu) |
MX (1) | MXPA02004350A (hu) |
NO (1) | NO20022057L (hu) |
OA (1) | OA12076A (hu) |
PE (1) | PE20011005A1 (hu) |
PL (1) | PL355261A1 (hu) |
SK (1) | SK7592002A3 (hu) |
TR (1) | TR200201211T2 (hu) |
TW (1) | TWI242431B (hu) |
WO (1) | WO2001032127A2 (hu) |
ZA (1) | ZA200203435B (hu) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100496607C (zh) | 2001-09-19 | 2009-06-10 | 尼科梅德有限责任公司 | Nsaid与pde-4抑制剂的并用药物 |
MXPA04003668A (es) * | 2001-10-31 | 2004-07-22 | Merck Patent Gmbh | Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos. |
UA82323C2 (uk) * | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань |
TW200410923A (en) * | 2002-10-17 | 2004-07-01 | Ono Pharmaceutical Co | Therapeutic agent for chronic obstructive pulmonary disease |
WO2004087149A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co. Ltd. | 医薬組成物 |
US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
CA2584169A1 (en) * | 2004-10-13 | 2006-04-20 | Kyowa Hakko Kogyo Co., Ltd. | Remedies/preventives for chronic skin disease |
WO2007045980A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type iv inhibitors |
CN104338219B (zh) | 2010-01-05 | 2017-10-24 | 微剂量治疗技术公司 | 吸入设备和方法 |
WO2015063669A1 (en) | 2013-10-30 | 2015-05-07 | Wockhardt Limited | Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2229221T3 (es) * | 1993-06-18 | 2005-04-16 | Smithkline Beecham Corporation | Procedimiento de identificacion de un inhibidor de pde iv. |
DE4332041C2 (de) * | 1993-09-21 | 1997-12-11 | Rentschler Arzneimittel | Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen |
PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
SE9801368D0 (sv) * | 1998-04-20 | 1998-04-20 | Astra Ab | New use |
-
2000
- 2000-10-31 AR ARP000105742A patent/AR029189A1/es not_active Application Discontinuation
- 2000-10-31 EC EC2000003747A patent/ECSP003747A/es unknown
- 2000-11-01 IL IL14936700A patent/IL149367A0/xx unknown
- 2000-11-01 AU AU13575/01A patent/AU1357501A/en not_active Abandoned
- 2000-11-01 CA CA002388333A patent/CA2388333A1/en not_active Abandoned
- 2000-11-01 PL PL00355261A patent/PL355261A1/xx not_active Application Discontinuation
- 2000-11-01 KR KR1020027005609A patent/KR20020057988A/ko not_active Application Discontinuation
- 2000-11-01 SK SK759-2002A patent/SK7592002A3/sk unknown
- 2000-11-01 CZ CZ20021512A patent/CZ20021512A3/cs unknown
- 2000-11-01 DZ DZ003225A patent/DZ3225A1/fr active
- 2000-11-01 EA EA200200518A patent/EA200200518A1/ru unknown
- 2000-11-01 MX MXPA02004350A patent/MXPA02004350A/es unknown
- 2000-11-01 EP EP00975533A patent/EP1225866A4/en not_active Withdrawn
- 2000-11-01 CN CN00815265A patent/CN1387404A/zh active Pending
- 2000-11-01 AP APAP/P/2002/002496A patent/AP2002002496A0/en unknown
- 2000-11-01 WO PCT/US2000/030113 patent/WO2001032127A2/en active Search and Examination
- 2000-11-01 TR TR2002/01211T patent/TR200201211T2/xx unknown
- 2000-11-01 HU HU0203152A patent/HUP0203152A3/hu unknown
- 2000-11-01 JP JP2001534335A patent/JP2003513028A/ja active Pending
- 2000-11-01 OA OA1200200124A patent/OA12076A/en unknown
- 2000-11-01 BR BR0015270-6A patent/BR0015270A/pt not_active IP Right Cessation
- 2000-11-02 PE PE2000001168A patent/PE20011005A1/es not_active Application Discontinuation
- 2000-11-02 CO CO00083427A patent/CO5261512A1/es not_active Application Discontinuation
- 2000-11-22 TW TW089123039A patent/TWI242431B/zh not_active IP Right Cessation
-
2002
- 2002-04-30 ZA ZA200203435A patent/ZA200203435B/xx unknown
- 2002-04-30 NO NO20022057A patent/NO20022057L/no not_active Application Discontinuation
- 2002-05-02 MA MA26621A patent/MA26841A1/fr unknown
- 2002-05-29 BG BG106748A patent/BG106748A/xx unknown
- 2002-12-19 HK HK02109234.5A patent/HK1049107A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2003513028A (ja) | 2003-04-08 |
BR0015270A (pt) | 2002-06-18 |
HUP0203152A3 (en) | 2004-06-28 |
CA2388333A1 (en) | 2001-05-10 |
AP2002002496A0 (en) | 2002-06-30 |
HUP0203152A2 (hu) | 2003-01-28 |
CN1387404A (zh) | 2002-12-25 |
NO20022057L (no) | 2002-06-27 |
PE20011005A1 (es) | 2001-09-28 |
PL355261A1 (en) | 2004-04-05 |
OA12076A (en) | 2006-05-04 |
KR20020057988A (ko) | 2002-07-12 |
NO20022057D0 (no) | 2002-04-30 |
DZ3225A1 (fr) | 2001-05-10 |
WO2001032127A2 (en) | 2001-05-10 |
EA200200518A1 (ru) | 2002-10-31 |
TWI242431B (en) | 2005-11-01 |
SK7592002A3 (en) | 2002-11-06 |
EP1225866A4 (en) | 2004-04-21 |
MA26841A1 (fr) | 2004-12-20 |
HK1049107A1 (zh) | 2003-05-02 |
ECSP003747A (es) | 2002-05-23 |
BG106748A (en) | 2003-02-28 |
EP1225866A2 (en) | 2002-07-31 |
TR200201211T2 (tr) | 2002-08-21 |
CO5261512A1 (es) | 2003-03-31 |
IL149367A0 (en) | 2002-11-10 |
WO2001032127A3 (en) | 2001-12-06 |
CZ20021512A3 (cs) | 2003-04-16 |
MXPA02004350A (es) | 2002-11-07 |
AU1357501A (en) | 2001-05-14 |
ZA200203435B (en) | 2003-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60114571D1 (de) | Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung | |
AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
DE69826644D1 (de) | Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker | |
BR0005299A (pt) | Compostos para o tratamento de disfução sexual feminina | |
ID29181A (id) | Kombinasi formoterol dan garam tiotropium | |
AR037255A1 (es) | Composiciones farmaceuticas que contienen oxibutinina | |
YU106192A (sh) | Nova kombinacija bronhodilatatora i steroidnog antiinflamatornog leka za lečenje respiratornih poremećaja | |
BR0306513A (pt) | tampão com medicamento | |
AR042262A2 (es) | Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
AR029189A1 (es) | Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento | |
BR9908617A (pt) | Nitroto inorgânico e ácido orgânico em combinação como uma composição antiviral tópica. | |
AR026197A1 (es) | Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina | |
BR0007613A (pt) | Aplicação de imidazo[1,5-a]-pirido[3,2-e]-pirazinonascomo medicamento | |
ES2188995T3 (es) | Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales. | |
BR0109747A (pt) | Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática | |
WO2004094373A3 (en) | A method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith | |
CR8584A (es) | Piperazinas derivadas de urea para el tratamiento de la endometrosis | |
AR010432A1 (es) | Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica | |
AR034036A1 (es) | Inhibidor de aromatasa en una dosis unica para tratar la infertilidad | |
PT927031E (pt) | Composicao farmaceutica que contem nimesulide para administracao por via oral | |
WO2001045727A3 (en) | Stabilized veterinary compositions comprising more than one antiviral agent | |
AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
WO2001001995A3 (en) | Method for treatment of asthma syndrome | |
BRPI0509305A (pt) | uso de um sensibilizador insulìnico, composição farmecêutica, e , kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |